Cantor and Nissel has announced the appointment of former ACLM chairman Chris Stean as a consultant to the company.

The former Allergan executive would take special responsibility for Cantor and Nissel’s regulatory affairs, CE and FDA registration and oversee the influence of Brexit, a statement said.

‘With 60% of the production being exported around the world and especially to Europe these areas are of great importance to Cantor and Nissel,’ the firm added.